Vestal Point Capital »

Macrogenics shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Macrogenics (MGNX) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Macrogenics

Tip: Access up to 7 years of quarterly data

All positions including Macrogenics held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Macrogenics by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.4M 800k 4.25

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Macrogenics

Bellevue Group
venBio Select Advisor
Armistice Capital
BlackRock
Vanguard Group
Millennium Management
Frazier Life Sciences Management
Daniel D. Thurber
RA Capital Management
State Street Corporation
Geode Capital Management
T. Rowe Price Associates
Two Sigma Investments
Two Sigma Advisers
Rock Springs Capital Management

View all funds holding Macrogenics